O'Dell Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,878
Closed -$10K 77
2020
Q4
$10K Buy
+14,878
New +$31.7K ﹤0.01% 67
2020
Q1
Sell
-10,846
Closed -$33K 63
2019
Q4
$33K Buy
+10,846
New +$28.2K 0.02% 62

Other funds holding BMY.RT

O'Dell Group's BMY.RT Position: Q1 2021 in Review

O'Dell Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 14,878 shares — an estimated $10K sold.

O'Dell Group first reported a position in BMY.RT in Q4 2019 and held it in 2 quarters. The position peaked at $33K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • O'Dell Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • O'Dell Group sold 14,878 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $10K.
  • O'Dell Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 2 quarters.
  • O'Dell Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $33K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on O'Dell Group's 13F filing for Q1 2021, filed 29 Apr 2021.